National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

synthetic human papillomavirus 16 E6 peptide
A synthetic peptide sequence of human papillomavirus (HPV) type 16 oncoprotein E6. The E6 oncoprotein is implicated in the tumorigenesis of cervical carcinoma. Vaccination with HPV 16 E6 peptide may stimulate the host immune system to mount a cytotoxic T lymphocyte (CTL) response against cells expressing the E6 oncoprotein, resulting in tumor cell lysis. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonyms:HPV-16 E6
HPV-16 E6 peptide
human papillomavirus 16 E6 peptide



Previous:Synestrin, Synovir, synthetic brain tumor peptides-pulsed autologous dendritic cell vaccine, synthetic breast cancer peptides-tetanus toxoid-Montanide ISA-51 vaccine, synthetic human corticotropin-releasing factor
Next:synthetic melanoma-associated antigens vaccine, synthetic peptide-based erythropoiesis stimulating agent, synthetic peptides E-PRA and E-PSM vaccine, Synthoestrin, Synthroid

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov